Table 1 Baseline patient’s characteristics and breakdown of the concomitant drugs
| Â | FD Number of patients. (%) |
|---|---|
Baseline patient’s characteristics | |
Total number of patients | 16 |
Age, median [IQR], years old | 57 [42, 73] |
Male:female | 6:10 |
Subtypes of FD | |
 PDS | 9 (47.4) |
 EPS | 7 (52.6) |
Overlap symptoms | |
 With NERD | 5 (31.3) |
 With IBS-C | 3 (18.8) |
 With chronic constipation | 1 (6.3) |
Concomitant drugs | |
Acid secretion inhibitor | |
 Esomeprazole magnesium hydrate | 5 (31.3) |
 Vonoprazan fumarate | 3 (18.8) |
Prokinetic agents | |
 Itoplide hydrochloride | 2 (12.5) |
 Acotiamide hydrochloride hydrate | 1 (6.3) |
Herbal medicine | |
 Rikkunshito | 6 (37.5) |
Laxative | |
 Magnesium oxide | 1 (6.3) |
Stool stabilizer | |
 Polycarbophil calcium | 1 (6.3) |